Alleva Lawrence M — SEC Form 4 filings
SEC reporting owner CIK 1553053. 13 Form 4 filings on record with FilingPulse; latest filed 2026-08-05.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-04-03 to 2026-08-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 38.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Mersana Therapeutics, Inc. (MRSN) | Director | 7 | — | — | 30 |
| Galera Therapeutics, Inc. (GRTX) | Director | 2 | — | — | 4 |
| BRIGHT HORIZONS FAMILY SOLUTIONS INC. (BFAM) | Director | 3 | — | — | 3 |
| Adaptimmune Therapeutics PLC (ADAP) | Director | 1 | — | — | 1 |
Form 4 filings — Alleva Lawrence M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-05 | 4 | Galera Therapeutics, Inc. (GRTX) | Disposition to issuer (D): 11 · Disposition to issuer (D): 40 · Disposition to issuer (D): 240 (derivative) | EDGAR |
| 2026-06-05 | 4 | BRIGHT HORIZONS FAMILY SOLUTIONS INC. (BFAM) | Grant/award (A): 2,096 | EDGAR |
| 2026-01-06 | 4 | Mersana Therapeutics, Inc. (MRSN) | Code (U): 578 · Code (U): 84 · Disposition to issuer (D): 2,460 (derivative) · Disposition to issuer (D): 800 (derivative) · Disposition to issuer (D): 142 (derivative) · Disposition to issuer (D): 400 (derivative) · +18 more | EDGAR |
| 2025-06-13 | 4 | Mersana Therapeutics, Inc. (MRSN) | Grant/award (A): 61,500 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | BRIGHT HORIZONS FAMILY SOLUTIONS INC. (BFAM) | Grant/award (A): 976 | EDGAR |
| 2025-02-26 | 4 | Galera Therapeutics, Inc. (GRTX) | Grant/award (A): 48,000 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Mersana Therapeutics, Inc. (MRSN) | Grant/award (A): 12,521 (derivative) @ $0 | EDGAR |
| 2024-10-03 | 4 | Mersana Therapeutics, Inc. (MRSN) | Grant/award (A): 9,615 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | Mersana Therapeutics, Inc. (MRSN) | Grant/award (A): 8,972 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | Adaptimmune Therapeutics PLC (ADAP) | Grant/award (A): 1,213,926 (derivative) @ $0 | EDGAR |
| 2024-06-12 | 4 | Mersana Therapeutics, Inc. (MRSN) | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | BRIGHT HORIZONS FAMILY SOLUTIONS INC. (BFAM) | Grant/award (A): 902 | EDGAR |
| 2024-04-03 | 4 | Mersana Therapeutics, Inc. (MRSN) | Grant/award (A): 3,996 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1553053 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →